MedTrace Logo

Fetal Loss in Women With Unprovoked Thromboembolism (FLUTE)

NCT00149357 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 239

Last updated 2017-03-23

No results posted yet for this study

Summary

The purpose of this study is to determine the risk of fetal loss in women with unprovoked venous thromboembolism (VTE) who do not have identifiable inherited thrombophilia compared with women who have the diagnosis of venous thromboembolism (VTE) excluded.

Conditions

  • Venous Thromboembolism
  • Fetal Death

Interventions

OTHER

Thrombophilia Testing

TP testing in Group 1 and 3 only

Sponsors & Collaborators

  • Canadian Institutes of Health Research (CIHR)

    collaborator OTHER_GOV

  • McMaster University

    lead OTHER

Principal Investigators

  • Huyen Tran, M.D. · McMaster University; Department of Medicine

  • Jeffrey Ginsberg, M.D. · McMaster University; Department of Medicine

  • Clive Kearon, M.D. · McMaster University; Department of Medicine

  • Jim Julian, M.Math · McMaster University; Dept. of Clinical Epidemiology & Biostatistics

  • Val Mueller, M.D. · McMaster University; Division of Obstetrics and Gynecology

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2005-07-31
Primary Completion
2008-02-29
Completion
2008-12-31

Countries

  • Australia
  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00149357 on ClinicalTrials.gov